Within this project, emphasis will be on gaining a better understanding of the mechanisms of action underlying successful immunological response of vaccines either alone or in combination therapies in humans based upon pre-clinical findings. This truly translational research area will use existing state-of the-art immunomonitoring and even improve it, such that it can also deliver more generic applicable strategies to be used in evaluating immunotherapeutics in general. Hélène van Meir (MD) has been appointed to work full-time in this emerging, but also challenging research area that shows a lot of promise, but has many unanswered questions. She will be supported by a team of immunologists, gynaecologists, oncologists and clinical pharmacologists.
Prof. Dr G. Kenter et al - NEJM 2009; 361: 1838-1847
